WU LIU
No ORCID on file
· 15 papers in corpus
· active 2008
Frequent coauthors
- JING JIANG 15
- PENG ZHU 15
- XINGHONG LUO 15
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…
2008
The invention relates to the application of a recombinant human blood vessel endothelium inhibin in pharmacy, in particular to the application for preparing medicines for treating endometriosis. The recombinant human blood vessel endotheliu…